# Bowel & Cancer Research

PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) registered in London, classed under “Other research and experimental development on natural sciences and engineering”.

- Company number: 05951118
- Status: Active
- Type: PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
- Incorporated: 29 September 2006
- Registered office: 1st Floor Abernethy Building, 2 Newark Street, London, E1 2AT
- Location: London
- Activity: Other research and experimental development on natural sciences and engineering

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Bowel & Cancer Research do?

PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) registered in London, classed under “Other research and experimental development on natural sciences and engineering”.

### How much turnover does Bowel & Cancer Research make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/bowel-cancer-research-05951118

### Is Bowel & Cancer Research profitable?

Bowel & Cancer Research's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Bowel & Cancer Research?

Its directors are Asha Senapati, Bowel Research UK. Its owners are shown to subscribers.

### Where is Bowel & Cancer Research based?

Its registered office is 1st Floor Abernethy Building, 2 Newark Street, London, E1 2AT, in London.

### When was Bowel & Cancer Research founded?

Bowel & Cancer Research was incorporated on 29 September 2006.

### Is Bowel & Cancer Research still trading?

The register lists Bowel & Cancer Research as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-06-23: Total exemption full accounts made up to 31 December 2025
- 2025-09-25: Termination of appointment of Richard James Charles Pertwee as a director on 14 May 2025
- 2025-06-26: Total exemption full accounts made up to 31 December 2024
- 2024-10-22: Total exemption full accounts made up to 31 December 2023
- 2023-10-05: Termination of appointment of Paul Adam Reynolds as a director on 5 October 2023
- 2023-10-05: Director's details changed for Ms Asha Senapati on 5 October 2023
- 2023-10-05: Director's details changed for Mr Richard James Charles Pertwee on 5 October 2023
- 2023-10-04: Total exemption full accounts made up to 31 December 2022
- 2023-03-22: Total exemption full accounts made up to 31 December 2021
- 2023-02-11: Compulsory strike-off action has been discontinued
- 2023-01-17: Compulsory strike-off action has been suspended
- 2022-11-29: First Gazette notice for compulsory strike-off
- 2022-02-27: Termination of appointment of Martine Julie Gabbitass as a secretary on 27 February 2022
- 2021-10-05: Total exemption full accounts made up to 31 December 2020
- 2021-05-26: Termination of appointment of Marilena Loizidou as a director on 26 May 2021
- 2021-05-26: Termination of appointment of Kathryn Pretzel Shiels as a director on 26 May 2021
- 2021-05-26: Appointment of Ms Asha Senapati as a director on 25 May 2021
- 2021-05-26: Appointment of Mr Richard James Charles Pertwee as a director on 25 May 2021
- 2021-02-09: Appointment of Bowel Research Uk as a director on 27 May 2020
- 2020-11-26: Termination of appointment of Jeremy Charles Hitchins as a director on 25 November 2020
- 2020-11-26: Termination of appointment of Christopher Roy Ellyatt as a director on 25 November 2020
- 2020-11-06: Accounts for a small company made up to 31 December 2019
- 2020-09-24: Termination of appointment of Charles Henry Knowles as a director on 24 September 2020
- 2020-06-03: Termination of appointment of Charles David Bueno De Mesquita as a director on 4 May 2020
- 2019-12-12: Termination of appointment of William Victor Peter Bullingham as a director on 5 December 2019

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/bowel-cancer-research-05951118